Pylote Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.56M
- Investors
-
4
Pylote General Information
Description
Developer of an antimicrobial technology designed to integrate into numerous consumers' products, through an exclusive in-house manufacturing process. The company's products offer attributes to materials and can be integrated into numerous consumer products without any change to the existing manufacturing process, enabling pharmaceutical, cosmetic, luxury, food, or industrial markets to provide end consumers with greener, cleaner and safer products.
Contact Information
Website
www.pylote.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Primary Office
- 22 Avenue de la Mouyssaguèse
- Dremil-Lafage
- 31280 Toulouse
- France
+33 05 00 00 00 00
Pylote Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 28-Apr-2022 | $1.56M | 00.000 | 00.000 | Completed | Generating Revenue |
| 2. Later Stage VC (Series A) | 07-Jan-2016 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 1. Accelerator/Incubator | Completed | Startup |
Pylote Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| ADP A | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| ADP B | 13,634 | $1.087058 | $21.93 | $21.93 | 1x | $21.93 | 3.18% | |
| ADP A | 32,500 | $1.087058 | $66.9 | $66.9 | 1x | $66.9 | 7.59% |
Pylote Patents
Pylote Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3004343-A1 | Spherical particles filled with colouring agents and method for obtaining such particles | Pending | 12-Nov-2015 | 0000000000 | |
| EP-3374436-A1 | Spherical particles filled with colouring agents | Pending | 12-Nov-2015 | 0000000000 | |
| FR-3043683-B1 | Spherical particles charged with coloring agents | Active | 12-Nov-2015 | 0000000000 | |
| FR-3043683-A1 | Spherical particles charged with coloring agents | Active | 12-Nov-2015 | 0000000000 | 0 |
| US-20190100657-A1 | Spherical particles filled with colouring agents | Active | 12-Nov-2015 | C09C1/3045 | 0 |
Pylote Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Loic Marchin | Co-Founder, Co-Chief Executive Officer & President | ||
| Marc Verelst | Co-Founder & Directeur général |
Pylote Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Didier Miraton | Pylote | Chairman of Supervisory Board | 000 0000 |
| Franck Lescure Ph.D | Auriga Partners (Paris) | Board Member | 000 0000 |
Pylote Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Pylote Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Auriga Partners (Paris) | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Elaia Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Galia Gestion | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Nubbo | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |